STOCK TITAN

ENDEXX CORP - EDXC STOCK NEWS

Welcome to our dedicated page for ENDEXX news (Ticker: EDXC), a resource for investors and traders seeking the latest updates and insights on ENDEXX stock.

Endexx Corporation (EDXC) is a pioneer in the plant-based wellness sector, offering high-quality m3cbd® hemp-based nutritional extracts rich in non-psychoactive phyto-cannabinoids and terpenoids. They also provide m3vape® starter kits and accessories to enhance the customer experience. Endexx is committed to formulating products that enhance bioavailability, affordability, and overall customer satisfaction. Their mission is to advance the understanding of cannabinoids through research and collaborations with medical professionals.

Recently, the company announced a strategic update on its auditing practices, opting to engage a new independent auditor, Victor Mokuolu, CPA PLLC, to align with their growth strategy and ensure transparency. This decision reflects Endexx's dedication to operational excellence and shareholder value.

Rhea-AI Summary

Endexx (OTC: EDXC) has announced a significant partnership between its HYLA™ division and American Shaman, a wellness retailer based in Kansas City, Missouri. This collaboration will introduce HYLA's no-nicotine vape products to 40 corporate-owned American Shaman locations, with potential expansion to 300 stores nationwide.

The partnership is part of Endexx's growth strategy, positioning HYLA for significant expansion in the domestic market. HYLA's products will be featured in a tray display program, focusing on educating consumers about nicotine-free alternatives. American Shaman's commitment to customer education and high-quality wellness products is expected to play a important role in introducing HYLA's products to a broader audience.

HYLA continues to target a compound annual growth rate (CAGR) of 300% over the next three to five years. This collaboration is anticipated to accelerate product distribution and market penetration, with more partnerships expected in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

Endexx (OTC: EDXC) has appointed Doug Williams, CPA, as Fractional CFO through his consulting firm, Alexander & Williams PLLC. This move is part of Endexx's efforts to strengthen its management team and implement a comprehensive financial roadmap. The roadmap includes:

  • Resuming audits with newly appointed auditors, Victor Mokuolu CPA PLLC (VMCPA)
  • Enhancing bookkeeping and accounting practices
  • Improving transparency and compliance
  • Streamlining operations for efficiency
  • Removing the 'yield' sign from OTC Markets profile

Brad Listermann, Interim CEO, expressed confidence in the company's path forward with the strengthened team and experienced auditors. Endexx remains committed to improving financial transparency, strengthening operations, and delivering long-term value to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.84%
Tags
management
-
Rhea-AI Summary

Endexx (OTC: EDXC), through its HYLA division, is expanding its market presence for plant-based wellness and non-nicotine vape products. Key developments include:

  • A pending $350,000+ purchase order from Dubai
  • Partnership with a 300-store chain, starting with a 40-store test launch
  • Distribution test with a regional convenience group
  • Discussions with national online distributors
  • Connections with large U.S. distributors, including a $50M+ vape distributor in Chicago
  • Expanding international footprint in Europe and Latin America
  • Verification on RangeMe.com, with submissions to major retailers

Endexx is optimistic about HYLA's growth trajectory, citing increasing interest from distributors and favorable industry trends. The company is also updating its accounting processes to ensure timely financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
none
Rhea-AI Summary

Endexx 's HYLA division has expanded its distribution network in Eastern Europe, marking a significant milestone in its global growth strategy. The company has successfully fulfilled new purchase orders totaling $124,500 to key Eastern European markets. These shipments are part of HYLA's broader efforts to expand its distribution network and drive sustained revenue growth in the region.

The company remains optimistic about its outlook, supported by strategic initiatives and robust partnerships. Endexx is focused on capitalizing on emerging opportunities and driving sustained growth as it navigates ongoing market dynamics in the vape products industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HYLA, a division of Endexx (OTC: EDXC), has successfully completed a major order delivery to Italy. The final shipment of 57,500 vape units was delivered today, completing the total order of 115,000 units. This order, valued at $414,000, marks a significant milestone in HYLA's international expansion efforts.

The initial half of the order was delivered in May 2024, and today's delivery ensures that Italian partners have the full complement of products to meet growing demand. This successful delivery demonstrates HYLA's efficient supply chain management and ability to fulfill large-scale orders promptly, strengthening its presence in the European market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.09%
Tags
none
-
Rhea-AI Summary

Endexx (OTC: EDXC) has issued a correction to its Q2 2024 financial report and highlighted significant revenue growth. The company clarified that the previously reported Q2 2024 revenue of $3,275,735 was actually for the six-month period ending March 31, 2024. The correct Q2 2024 revenue (three months ending March 31, 2024) is $2,181,012.

Despite the reporting error, Endexx achieved notable financial results:

  • Revenue of $3,275,735 for the six-month period ending March 31, 2024
  • Gross profit of $1,246,677 for Q2 2024
  • Net income of $506,837 for Q2 2024, a significant improvement from the previous quarter's net loss of $828,902

Interim CEO Brad Listermann emphasized the company's commitment to transparency and continued focus on delivering value through innovative products and strategic market expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.02%
Tags
none
Rhea-AI Summary

Endexx (OTCQB: EDXC) reported its Q2 2024 financial results, showing a 33.42% decrease in revenue to $2,181,012 and a 34.16% decrease in gross profit to $1,246,677 compared to Q1 2024. However, the company's net loss improved by 55.27% to $905,615. Interim CEO Brad Listermann highlighted improved cash management, with net cash used in operating activities improving by 53.44% and cash at the end of the period increasing by 187.15%. The company is focusing on the growing vaping industry, positioning its HYLA brand of organic, plant-based, zero-nicotine vape products. Strategic initiatives include exploring roll-up acquisitions, enhancing direct-to-consumer efforts, and expanding distribution channels, with potential partnerships in progress with major retailers and convenience store chains.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
-
Rhea-AI Summary

Endexx (OTC: EDXC), a provider of plant-based wellness and nutritional products, has released a new CEO Guidance Report for Shareholders. The report, issued on July 26, 2024, outlines the company's recent developments, strategic initiatives, and future outlook. While specific details of the report are not provided in the press release, it suggests that Endexx is taking steps to communicate its business strategy and performance to investors.

The issuance of a CEO Guidance Report indicates that Endexx is prioritizing transparency and shareholder communication. Such reports typically offer insights into a company's financial health, market position, and growth plans, which can be valuable for investors in making informed decisions. However, without access to the full report, the exact nature of the guidance and its potential impact on Endexx's stock performance remains unclear.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.02%
Tags
management
-
Rhea-AI Summary
Endexx (EDXC) has reported substantial financial growth and market expansion in its annual financial results for the fiscal year ending September 30, 2023. The company achieved a remarkable revenue increase of $3,908,385 in 2023, up 83% from the previous year. Endexx also expanded its global footprint, with notable revenue contributions from Italy. The company's total assets stood at $10,328,161, showcasing effective asset management practices. Endexx is dedicated to sustaining its growth trajectory through strategic marketing, product innovation, and international market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.32%
Tags
Rhea-AI Summary
Endexx (OTC: EDXC) rebrands to HYLA and secures a $348,812.50 distribution agreement with a Houston distributor, signaling a significant step in market expansion. The deal is expected to drive substantial revenue growth through quarterly orders of proprietary wellness products. CEO Nick Mehdi anticipates multimillion-dollar revenues and enhanced market presence, highlighting a strategic shift towards innovation and environmental stewardship.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.86%
Tags
none

FAQ

What is the current stock price of ENDEXX (EDXC)?

The current stock price of ENDEXX (EDXC) is $0.0098 as of October 15, 2024.

What is the market cap of ENDEXX (EDXC)?

The market cap of ENDEXX (EDXC) is approximately 6.5M.

What products does Endexx Corporation offer?

Endexx Corporation provides high-quality m3cbd® hemp-based nutritional extracts rich in non-psychoactive phyto-cannabinoids and terpenoids. They also offer m3vape® starter kits and accessories.

What is Endexx's mission?

Endexx Corporation aims to advance the understanding of cannabinoids through research and collaborations with medical professionals. They strive to offer products that enhance bioavailability, affordability, and customer satisfaction.

What recent strategic update did Endexx announce?

Endexx Corporation recently engaged Victor Mokuolu, CPA PLLC, as their new independent auditor to align with their growth strategy and ensure transparency in their auditing practices.

How does Endexx Corporation demonstrate its commitment to operational excellence?

Endexx Corporation demonstrates its commitment to operational excellence by making strategic decisions that enhance transparency, align with their growth strategy, and uphold the highest standards of accuracy in their financial reporting.

What sets Endexx Corporation apart in the plant-based wellness sector?

Endexx Corporation sets itself apart in the plant-based wellness sector by offering high-quality, innovative products that focus on enhancing bioavailability, affordability, and customer satisfaction. Their dedication to research and collaboration with medical professionals further distinguishes them in the industry.

ENDEXX CORP

OTC:EDXC

EDXC Rankings

EDXC Stock Data

6.53M
477.91M
6.34%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Cave Creek